Shareholder Structure

Capital Structure

As of April 15, 2025, the company has 16,392,754 issued shares (including 1,372 treasury shares held by SHL, which are dormant shares and have no rights) with a nominal value of NIS 0.01 each (Corresponding to 16,391,382 voting rights)

Ownership Structure

As of April 15, 2025, SHL was aware of the following shareholders with more than 3% of all voting rights in the company:

Capital Structure

As of December 5,2025, the company has 37,059,946 issued shares (including 1,372 treasury shares held by SHL, which are dormant shares and have no rights) with a nominal value of NIS 0.01 each (Corresponding to 37,058,574 voting rights)

Ownership Structure

As of December 5,2025, SHL was aware of the following shareholders with more than 3% of all voting rights in the company:


Number

Including Treasury Shares

%

Excluding Treasury Shares %

Cai Mengke and Shen Kun

5,969,413

36.41%

36.42%

More Provident Funds

2,111,576

12.90%

12.90%

Value Base Group

1,406,236

8.58%

8.58%

Yariv Alroy

801,456

4.89%

4.89%

Danbar Finance Ltd.

791,405

4.83%

4.83%

Sphera Funds Management Ltd.

632,456

3.86%

3.86%

Treasury shares

1,372

0.01%

Public

4,678,840

28.50%

28.50%

Total

16,392,754

100%

100%


Number

Including Treasury Shares

%

Cai Mengke and Shen Kun

5,632,725

15.20%

Value Base Group

5,624,944

15.18%

Danbar Finance Ltd.

3,165,620

8.54%

More Provident Funds

1,962,525

5.30%

Matag Investments Ltd

1,919,144

5.18%

Dani Rimoni

1,764,308

4.76%

David Wertheim

1,476,420

3.98%

Baruch Arlich

1,431,592

3.86%

Sphera Funds Management Ltd

1,116,392

3.13%

Treasury shares

1,372

0.00%

Public

12,920,904

34.86%

Total

37,059,946

100%

The above table of Significant Shareholders reflects both actual holdings as of  December 5,2025, excluding options and any other purchase positions, after deducting from the total number of shares outstanding 1,372 Ordinary Shares held by SHL, and actual holdings as of December 5,2025 calculated including ordinary shares held by SHL, all as indicated above, but does not reflect holdings on a fully diluted basis. All in accordance with notifications received by the Company from its shareholders as of December 5,2025.

Disclosure of Management Transactions

SHL Telemedicine has to report to SIX Swiss Exchange all transactions of SHL shares and options made by the Board of Directors and the executive management. The disclosure of management transactions is intended as a means of furthering the supply of information to investors. Such disclosure provides investors with additional qualitative insight with regard to their investment decision.
Click here for the Management Transaction disclosure of SHL Telemedicine on the SIX-Platform.